TRC-093

N/A

Report date: 2025/03/26 13:54:05

Base Information

Drug NameTRC-093
Drug Alias NameD-93MT-293TRC-093
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCollagen modulatorsAngiogenesis inhibitors
TargetsCollagen
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMicromet Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTracon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A